Yukie Saitoh

Title: The Innovative Contributions of Yukie Saitoh

Introduction

Yukie Saitoh is a prominent inventor based in Komagane, Japan. She has made significant strides in the field of biotechnology, particularly in the development of antibodies with anti-cancer activity. Her work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Yukie Saitoh holds a patent for an antibody that exhibits anti-cancer activity. By utilizing an SST-REX method, she selected a cDNA encoding a protein expressed on a cell surface or secreted from a cancer cell line from a cDNA library derived from a cancer cell line. Monoclonal antibodies against the protein encoding the selected cDNA were prepared. The in vitro and in vivo anti-cancer activities and binding to various cancer cell lines were examined. As a result, a monoclonal antibody that binds to a PODXL2 protein, which had excellent anti-cancer activities, was found. Furthermore, a region including an epitope of the antibody was successfully identified, and the amino acid sequences of variable regions of a light chain and a heavy chain were successfully determined. She has 1 patent to her name.

Career Highlights

Yukie Saitoh is currently associated with Actgen Inc., where she continues her research and development efforts. Her innovative work in antibody development showcases her commitment to advancing medical science and improving therapeutic options for cancer patients.

Collaborations

Yukie has collaborated with notable colleagues, including Masahito Sugiura and Kazuyuki Atarashi. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Yukie Saitoh's contributions to the field of biotechnology, particularly in the development of anti-cancer antibodies, highlight her innovative spirit and dedication to improving healthcare. Her work is a testament to the impact that dedicated inventors can have on society.